SYP and neoplasm: Unexpectedly, immunostainings highlighted tumor components displaying a robust and diffuse GFAP immunoreactivity, usually not present in MB, along with tumor areas displaying a classical immunoreactivity for Synaptophysin (Fig. 3A, B).